Search by Drug Name or NDC

    NDC 55150-0352-01 IRINOTECAN HYDROCHLORIDE 20 mg/mL Details

    IRINOTECAN HYDROCHLORIDE 20 mg/mL

    IRINOTECAN HYDROCHLORIDE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is IRINOTECAN HYDROCHLORIDE.

    Product Information

    NDC 55150-0352
    Product ID 55150-352_4b122664-72ee-402e-a2b3-806c236f486c
    Associated GPIs 21550040102025
    GCN Sequence Number 062173
    GCN Sequence Number Description irinotecan HCl VIAL 40 MG/2 ML INTRAVEN
    HIC3 V3E
    HIC3 Description ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS
    GCN 97955
    HICL Sequence Number 010778
    HICL Sequence Number Description IRINOTECAN HCL
    Brand/Generic Generic
    Proprietary Name IRINOTECAN HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name IRINOTECAN HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name IRINOTECAN HYDROCHLORIDE
    Labeler Name Eugia US LLC
    Pharmaceutical Class Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213278
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0352-01 (55150035201)

    NDC Package Code 55150-352-01
    Billing NDC 55150035201
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-352-01) / 2 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2020-02-11
    NDC Exclude Flag N
    Pricing Information N/A